Vanguard Global Advisers’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
44,777
-1,626
-4% -$37.7K ﹤0.01% 1664
2026
Q1
$955K Buy
+46,403
New +$1.05M ﹤0.01% 1676

Other funds holding PRVA

Vanguard Global Advisers's PRVA Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Privia Health (PRVA) stake by 3.5% in Q2 2026, selling an estimated $37.7K and leaving 44,777 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1664.

Vanguard Global Advisers first reported a position in PRVA in Q1 2026 and has held it in 2 quarters since. 300 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Vanguard Global Advisers held 44,777 shares of Privia Health worth $1.15M as of Q2 2026.
  • Vanguard Global Advisers sold 1,626 Privia Health shares in Q2 2026, an estimated $37.7K.
  • Privia Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1664 holding.
  • Vanguard Global Advisers first reported a position in Privia Health in Q1 2026 and has held it in 2 quarters since.
  • 300 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.